Physician

Praful M. Kelkar, M.D.

According to 2025 Medicare claims, Praful Kelkar, M.D. (NPI: 1588656417) practices neurology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Hennepin, MN. This provider's primary affiliated billing organization is MINNEAPOLIS CLINIC OF NEUROLOGY, LTD (NPI: 1992739247; TIN: 410999094) and primary practice location at 55422-4215.

Kelkar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 207 traditional Medicare patients, billed 23,237 HCPCS/CPT codes, and received $1,407,720 in Medicare payments. The top billing code was 95910 (Nerve conduction, 7-8 studies). Part D data shows 1,083 prescription claims across 222 beneficiaries totaling $324,450 in drug costs, led by Carbidopa-Levodopa (Carbidopa/Levodopa). DME data shows 48 claims. Open Payments data shows 4 records totaling $66. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $53,696 to $1,407,720. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $575,185 and ending at $324,450. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	219	1,813	$53,696
2016	217	1,665	$56,877
2017	239	1,829	$54,518
2018	231	2,115	$62,581
2019	323	3,901	$101,577
2020	294	7,297	$151,810
2021	304	22,177	$577,373
2022	275	26,048	$672,163
2023	245	24,478	$691,377
2024	207	23,237	$1,407,720

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	186	982	$575,185
2016	180	924	$632,061
2017	221	1,060	$584,596
2018	214	1,082	$641,812
2019	230	1,152	$467,093
2020	203	1,085	$326,116
2021	260	1,188	$446,825
2022	246	1,232	$539,201
2023	250	1,215	$535,546
2024	222	1,083	$324,450

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	16	$4,020
2023	N/R	50	$3,757
2024	N/R	48	$2,394

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95910	Nerve conduction, 7-8 studies	17	18	$130
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	58	73	$114
95909	Nerve conduction, 5-6 studies	21	21	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	22	22	$86
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	58	78	$72

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Carbidopa-Levodopa	Carbidopa/Levodopa	109	7,639	$4,713
Carbamazepine Er	Carbamazepine	29	1,110	$4,148
Sumatriptan Succinate	Sumatriptan Succinate	22	278	$3,621
Primidone	Primidone	62	2,935	$3,213
Lacosamide	Lacosamide	24	872	$2,509

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	12	$1,353
A4349	Male external catheter, with or without adhesive, disposable, each	N	N/R	12	$709
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	N/R	12	$249
A4402	Lubricant, per ounce	N	N/R	12	$82

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$66	Takeda Pharmaceuticals U.S.A., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Praful M. Kelkar, M.D.?

Tedicare shows public-source Medicare data for Praful M. Kelkar, M.D. (NPI 1588656417), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Praful M. Kelkar, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Praful M. Kelkar, M.D.?

Praful M. Kelkar, M.D. is linked to MINNEAPOLIS CLINIC OF NEUROLOGY, LTD (billing NPI 1992739247) in the available physician profile data.

Does Praful M. Kelkar, M.D. have Open Payments data?

Praful M. Kelkar, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.